Twist Bioscience Corporation
TWST
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital dā¦ read more
Healthcare
Diagnostics & Research
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$30.27
Price-1.18%
-$0.36
1Y
Price
Market Cap
$1.827b
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-25.0%
EBITDA Margin+21.2%
Net Profit Margin-11.0%
Free Cash Flow MarginRevenue
$362.273m
+15.8%
1y CAGR+21.3%
3y CAGR+29.4%
5y CAGREarnings
-$85.187m
+59.2%
1y CAGR+21.1%
3y CAGR+5.0%
5y CAGREPS
-$1.46
+59.4%
1y CAGR+23.4%
3y CAGR+10.5%
5y CAGRBook Value
$478.198m
$643.605m
Assets$165.407m
Liabilities$78.150m
DebtDebt to Assets
12.1%
-0.6x
Debt to EBITDAFree Cash Flow
-$68.713m
+0.7%
1y CAGR+28.3%
3y CAGR+5.6%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company